National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Zoledronic Acid

Synonyms

Zoledronate

NDC-Zoledronate

[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid

zoledronic acid

Zoledronic acid

Zoledronic Acid

ZOLEDRONIC ACID

Aclasta

CGP 42446

CGP42446A

Reclast

ZOL 446

Zometa

Definitions

A synthetic imidazole bisphosphonate analog of pyrophosphate with anti-bone-resorption activity. A third-generation bisphosphonate, zoledronic acid binds to hydroxyapatite crystals in the bone matrix, slowing their dissolution and inhibiting the formation and aggregation of these crystals. This agent also inhibits farnesyl pyrophosphate synthase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. Decreased bone turnover and stabilization of the bone matrix contribute to the analgesic effect of zoledronic acid with respect to painful osteoblastic lesions. The agent also reduces serum calcium concentrations associated with hypercalcemia.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1699

Accepted_Therapeutic_Use_For

Hypercalcemia of malignancy; Multiple myeloma and metastatic bone lesions from solid tumors; Paget's disease

ALT_DEFINITION

A drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with other drugs to treat multiple myeloma and to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone. It is a type of bisphosphonate.

CAS_Registry

165800-06-6

Chemical_Formula

C5H10N2O7P2.H2O

code

C1699

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C179531

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C179478

Contributing_Source

CTRP

FDA

GDC

HemOnc

PCDC

DEFINITION

A synthetic imidazole bisphosphonate analog of pyrophosphate with anti-bone-resorption activity. A third-generation bisphosphonate, zoledronic acid binds to hydroxyapatite crystals in the bone matrix, slowing their dissolution and inhibiting the formation and aggregation of these crystals. This agent also inhibits farnesyl pyrophosphate synthase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. Decreased bone turnover and stabilization of the bone matrix contribute to the analgesic effect of zoledronic acid with respect to painful osteoblastic lesions. The agent also reduces serum calcium concentrations associated with hypercalcemia.

Display_Name

Zoledronic Acid

FDA_UNII_Code

6XC1PAD3KF

FULL_SYN

Zoledronate

NDC-Zoledronate

[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic Acid

zoledronic acid

Zoledronic acid

Zoledronic Acid

ZOLEDRONIC ACID

Aclasta

CGP 42446

CGP42446A

Reclast

ZOL 446

Zometa

Has_Salt_Form

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66703

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C80325

Is_Value_For_GDC_Property

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1909

label

Zoledronic Acid

Legacy Concept Name

Zoledronate

Maps_To

Zoledronic Acid

NCI_Drug_Dictionary_ID

42507

NSC Number

721517

PDQ_Closed_Trial_Search_ID

42507

PDQ_Open_Trial_Search_ID

42507

Preferred_Name

Zoledronic Acid

prefixIRI

Thesaurus:C1699

Semantic_Type

Organic Chemical

Pharmacologic Substance

UMLS_CUI

C0257685

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C443

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2136

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C67439

Delete Subject Author Type Created
No notes to display